Northstar Global Business Services, Inc. announces that retail
product has started shipping to stores, as projected sales for 2013
are Increased
HOLBROOK, N.Y., Nov. 26, 2012 /PRNewswire/ -- Northstar Global
Business Services, Inc. Symbol (OTCPink: MDIN) today announced that
its flagship product, Snorenz®, is already being shipped to stores,
and being put on shelves. This is a full month ahead of the
scheduled release, previously set for January 1st. Starting with individual
pharmacies, convenience and health-food stores, the product has
been in production, and is being shipped out to retail stores that
have already placed orders over the past weeks.
"We are very proud of what we have accomplished. In less than a
year, to be in this position is truly overwhelming," said Company
CEO Nick Chieco. "I never thought we
would be starting off December with accumulated orders and product
being shipped. Now, product being shipped to large retail chains
typically takes much longer to actually hit shelves, but customers
should be able to buy Snorenz® in some stores, including
independent retail locations right now,"He added
enthusiastically.
The company is currently being overwhelmed with interest in
the product. So much, that projections of Snorenz® sales are
conservatively estimated at over twelve million units for the
calendar year of 2013, nearly three times the product's best year
ever. The success may have something to do with the
economics, which have become much more attractive to retailers
since last produced. The product is said to cost approximately only
$1.47 US dollars to produce with a
wholesale price of just $3.89
allowing for the two ounce bottle to retail for just $6.99, while giving retailers a whopping 79%
markup. The lower pricepoint means more projected sales and deeper
market penetration. Management wants to make clear that these
projections are based on retailer demands, and at the moment its
manufacturing capabilities would actually not be able to keep up
with this level of production if not expanded immediately. For this
reason the company now plans to do its own fulfillment and
warehousing for product sold directly to consumers, and eventually
for all independent stores as well, which it is in the process of
implementing. Additionally, manufacturers are being approached in
the US and abroad to increase production to match expected demand
levels. Since the company's production and marketing are being
ramped up with limited up front funding, the lion's share of the
revenue is slated to come in the third and fourth quarters of the
calendar year. Primarily this is tied to the Net 90 day terms most
retail operates on. The company adds that in addition to Snorenz®
it has several other products for which projected sales will be
released at a later date. The company also plans to soft release
several new products this year in its stem cell therapy line, so
they expect projections overall to be staggering.
As for where you can buy Snorenz® right now, specific locations
are not being disclosed just yet to protect these locations from
spending limited resources answering calls from investors and
shareholders eagerly seeking more information, but the list will be
posted on the company website very soon so that consumers know
where to go until the company reaches its goal of having product on
the shelves of every major retail outlet in the US. Merchants
interested in carrying Snorenz® are encouraged to contact the
company at 1-877-571-4387 Ext 4 (Sales).
About Northstar
Northstar Global Business Services is a business services company
with a division called "MedGen Healthcare Products", dedicated to
producing alternative healthcare products. The three most popular
products in Northstar's arsenal are Snorenz©, Painenz©, and
"Good Night's Sleep", an FDA approved sleep aid. All products use
the company's patented spray delivery system and have received very
positive consumer reviews all over the world, and sold million upon
millions of units from 1996 to the present.
This Press Release may contain certain forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. The Company has tried, whenever possible, to
identify these forward-looking statements using words such as
"anticipates," "believes," "estimates," "expects," "plans,"
"intends," "potential" and similar expressions. These statements
reflect the Company's current beliefs and are based upon
information currently available to it. Accordingly, such
forward-looking statements involve known and unknown risks,
uncertainties and other factors which could cause the Company's
actual results, performance or achievements to differ materially
from those expressed in or implied by such statements. The Company
undertakes no obligation to update or advise in the event of any
change, addition or alteration to the information catered in this
Press Release including such forward-looking statements.
SOURCE Northstar Global Business Services, Inc.